Statistics
Publications
19
Citations
805
H-Index
15
Active since
2018
Qianying Liu is an author at Sanofi (United States) specializing in medicine, oncology, and plerixafor mobilization.
Publications per year
2018–2025
19
19
High-throughput screening identifies established drugs as SARS-CoV-2 PLpro inhibitors
Yao Zhao, Xiaoyu Du, Yinkai Duan et al. · Protein & Cell · 2021 · 155 citations · Full text
Jun Wang, Qianying Liu, Haotian Xie et al. · Cancers · 2021 · 105 citations · Full text
Medicine, Computer Science, Oncology +17
Joseph Mıkhael, Paul G. Richardson, Saad Z. Usmani et al. · Blood · 2019 · 90 citations · Full text
Medicine, Hematology, Oncology +14
Sara M. Tolaney, Arlene Chan, Katarína Petráková et al. · Journal of Clinical Oncology · 2023 · 74 citations · Full text
Medicine, Oncology, Pharmacology +17
Early fusion intermediate of ACE2-using coronavirus spike acting as an antiviral target
Lixiao Xing, Zhimin Liu, Xinling Wang et al. · Cell · 2025 · 41 citations
1–5 of 19